一种针对安非他胺诱导的行为敏感化的拟议机制,涉及囊泡单胺转运器
Valeria Garcia1, Stephen A Collins2, Edith Hernandez1
1Department of Psychology, The University of Texas at El Paso, El Paso, TX 79968, USA.
Brain research
|July 20, 2025
概括
在安非他命 (AMPH) 敏感化诱导过程中,囊泡单胺转运体 (VMAT) 阻塞与四甲 (TBZ) 阻止了随后的AMPH和电刺激行为敏感化,这表明VMAT.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 氨基胺 (AMPH) 敏感化涉及多巴胺 (DA) 信号传递中的神经适应性变化.
- 囊泡单胺转运体 (VMAT) 调节DA包装到囊泡中,影响其释放.
- 了解VMAT在AMPH敏感化中的作用对于成研究至关重要.
研究的目的:
- 调查VMAT是否调节AMPH敏感化的表达.
- 为了确定在AMPH敏感化诱导期间阻止VMAT是否会影响随后的AMPH唤起和脱极化引起的行为.
主要方法:
- 鼠每天接受AMPH注射 (诱导阶段) 含有或没有VMAT阻断剂tetrabenazine (TBZ).
- 通过单方面耗尽大鼠的AMPH引起的旋转行为和完整大鼠的电刺激旋转行为 (ESRB) (表达阶段) 来评估敏感性.
主要成果:
- 在诱导减弱AMPH引起的旋转期间的TBZ预处理.
- 在诱导期间的TBZ预处理在表达阶段阻止了AMPH引起和ESRB的敏感化.
- 这些发现表明VMAT在敏感化期间的DA再分配中的作用.
结论:
- VMAT 功能性地调节了 AMPH 敏感度.
- 对于行为敏感化的发展来说,VMAT在重新分配神经内DA池中的作用至关重要.
- 针对VMAT可能为物质使用障碍提供治疗策略.
相关概念视频
01:25Adrenergic Agonists: Indirect-Acting Agents
1.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.9K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
01:26Neurochemical Transmission: Sites of Drug Action
2.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.7K
01:15Drug Abuse and Addiction: Pharmacological Phenomena
659
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
659
01:20Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K